CBD 100 mg/mL Oral Solution
PID-18894
Phase 3 small_molecule active
Quick answer
CBD 100 mg/mL Oral Solution for Treatment Resistant Psychosis is a Phase 3 program (small_molecule) at COGNITION THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- COGNITION THERAPEUTICS INC
- Indication
- Treatment Resistant Psychosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active